First Abu Dhabi Bank EMTN US$30bn Second Suppl.
FAB updates its $30 billion EMTN programme with a new regulatory supplement.
What the company is saying
First Abu Dhabi Bank P.J.S.C. has issued a Second Supplement dated 6 October 2026 to its Base Prospectus for the Euro Medium Term Note Programme. The announcement frames the supplement as a required regulatory update, emphasizing that it must be read in conjunction with the original Base Prospectus dated 3 July 2026. The Programme allows for the issuance of up to U.S.$30,000,000,000 in aggregate nominal amount of notes, a figure highlighted in both the supplement and the summary. The issuer reiterates that all relevant documentation is available on its Investor Relations website, directing investors to primary sources for further detail. The tone is strictly procedural, with no attempt to promote or highlight potential financial benefits or upcoming issuances. No executives are named, and no commentary or forward-looking statements are included.
What the data suggests
The only quantitative disclosure is the Programme's maximum issuance capacity of U.S.$30,000,000,000, which defines the structural ceiling for future note issuances but does not indicate any actual or imminent capital raising. The supplement is dated 6 October 2026, and the Base Prospectus is dated 3 July 2026, confirming the timeline of regulatory filings. There are no figures on notes already issued, proceeds raised, or financial performance metrics. The announcement is complete and transparent for its regulatory purpose but does not provide operational or financial trend data. An independent analyst would conclude that this is a routine documentation update, not a signal of new funding activity or a change in financial trajectory.
Analysis
The announcement is a routine regulatory disclosure regarding the issuance of a supplement to the base prospectus for First Abu Dhabi Bank's Euro Medium Term Note Programme. All claims are factual, realised, and procedural, with no forward-looking statements or promotional language. The mention of the Programme's capacity (up to U.S.$30,000,000,000) is a structural feature, not a claim of imminent issuance or financial impact. There is no attempt to frame the update as a value-creating event or to suggest near-term benefits to investors. No capital outlay or earnings impact is discussed, and no timeline for note issuance or proceeds deployment is provided. The language is strictly informational and proportionate to the content.
Risk flags
- ●The absence of detail on actual note issuances means investors cannot assess near-term funding plans or potential dilution, leaving uncertainty about when or if the $30 billion capacity will be utilized.
- ●No information is provided on the terms, pricing, or market appetite for future notes, which could affect the cost and success of future capital raising.
- ●As a regulatory update, the supplement does not address credit risk, counterparty risk, or macroeconomic factors that could impact the Programme's effectiveness or investor demand.
Bottom line
This announcement is a procedural update confirming that First Abu Dhabi Bank's $30 billion Euro Medium Term Note Programme remains in force and that the latest supplement is now part of the official documentation. There is no disclosure of new note issuances, pricing, or proceeds, so investors gain no insight into near-term funding activity or financial impact. The company provides all required regulatory information, but the update is non-actionable for investors seeking signals on capital raising or operational performance. The most important takeaway is that the Programme's capacity and documentation are current, but any real financial consequences will depend on future, separately announced note issuances.
Announcement summary
(LSE:13SG) First Abu Dhabi Bank P.J.S.C. has issued a Second Supplement dated 6 October 2026 to its Base Prospectus dated 3 July 2026. The supplement forms part of and must be read in conjunction with the Base Prospectus prepared in connection with the Bank's Euro Medium Term Note Programme. The Programme allows for the issuance of up to U.S.$30,000,000,000 in aggregate nominal amount of notes. The supplement and the Base Prospectus are available on the First Abu Dhabi Bank Investor Relations website. The issuer of the notes is First Abu Dhabi Bank P.J.S.C. The supplement is a regulatory document required for the ongoing Euro Medium Term Note Programme. The London Stock Exchange has published the supplement as a regulatory news service announcement. The Financial Conduct Authority has approved RNS as a Primary Information Provider in the United Kingdom. The supplement is dated 6 October 2026. The Base Prospectus is dated 3 July 2026. The Programme is for the issuance of notes up to U.S.$30,000,000,000 in aggregate nominal amount. The supplement must be read together with the Base Prospectus for full information on the Programme.
Disagree with this article?
Ctrl + Enter to submit